Cargando…
Tarlatamab: the promising immunotherapy on its way from the lab to the clinic
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326778/ https://www.ncbi.nlm.nih.gov/pubmed/37425422 http://dx.doi.org/10.21037/tlcr-23-115 |
| _version_ | 1785069492986970112 |
|---|---|
| author | Tang, Daolin Kang, Rui |
| author_facet | Tang, Daolin Kang, Rui |
| author_sort | Tang, Daolin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10326778 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103267782023-07-08 Tarlatamab: the promising immunotherapy on its way from the lab to the clinic Tang, Daolin Kang, Rui Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-03-20 2023-06-30 /pmc/articles/PMC10326778/ /pubmed/37425422 http://dx.doi.org/10.21037/tlcr-23-115 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Tang, Daolin Kang, Rui Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title | Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title_full | Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title_fullStr | Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title_full_unstemmed | Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title_short | Tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| title_sort | tarlatamab: the promising immunotherapy on its way from the lab to the clinic |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326778/ https://www.ncbi.nlm.nih.gov/pubmed/37425422 http://dx.doi.org/10.21037/tlcr-23-115 |
| work_keys_str_mv | AT tangdaolin tarlatamabthepromisingimmunotherapyonitswayfromthelabtotheclinic AT kangrui tarlatamabthepromisingimmunotherapyonitswayfromthelabtotheclinic |